AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DIMENHYDRINATE

12 registrations across 4 African markets— 9 active

Markets with DIMENHYDRINATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DRAMAMINE LIQUID🇿🇦South AfricaPHARMACIA SOUTH AFRICA (PTY) LTDsuspendedNov 2021
DRAMAMINE 50MG TABLET
TABLET
🇲🇼MalawiexpiredJun 1996
DRAMAMINE 15.6MG/5ML ORAL LIQUID
ORAL LIQUID
🇲🇼MalawiexpiredJun 1996
DIMENHYDRINATE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DRAMAMINE
COMPRIME PELLICULE QUADRISECABLE
🇲🇦Moroccoactive
DIMENHYDRINATE
ORAL LIQUID ORDINARY SYRUPS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive
DIMENHYDRINATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaSEARLE PAKISTAN LIMITEDactive

DIMENHYDRINATE in Africa — Regulatory Overview

DIMENHYDRINATE is registered across 4 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Morocco, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 9 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.